A real-time fluorescent nucleic acid constant temperature amplification detection kit for hepatitis B virus hbv

A hepatitis B virus, constant temperature amplification detection technology, applied in the field of probes, related kits, and primers, can solve the problems of inability to detect nine HBVA-I genotypes, poor specificity and sensitivity, etc. Ease of automation, broad coverage, and reduced amplification and detection time

Active Publication Date: 2019-07-16
SHANGHAI RENDU BIOTECH
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, this kit also solves the technical problem that the hepatitis B detection kits in the prior art have poor specificity and sensitivity and cannot detect all nine genotypes of HBVA-I

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A real-time fluorescent nucleic acid constant temperature amplification detection kit for hepatitis B virus hbv
  • A real-time fluorescent nucleic acid constant temperature amplification detection kit for hepatitis B virus hbv
  • A real-time fluorescent nucleic acid constant temperature amplification detection kit for hepatitis B virus hbv

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0124] Embodiment 1, be used for the design of the special primer and probe of real-time fluorescent nucleic acid constant temperature amplification detection hepatitis B virus HBV

[0125] The present invention selects hepatitis B virus surface antigen S gene (its nucleotide sequence is as shown in sequence 8 in the sequence listing) to carry out primer probe design, obtains following concrete sequence:

[0126] (1) nT7 primers and T7 primers for amplifying the hepatitis B virus target polynucleotide, the nucleotide sequence of the nT7 primer is: 5'-GATGTGTCTGCGGCGTTTTA-3' (sequence 2); the nucleotide sequence of the T7 primer is: 5'-AATTTAATACGACTCACTATAGGGAGAACAAACGGGCAACATACCTT-3' (SEQ ID NO: 1);

[0127] (2) A detection probe for detecting the hepatitis B virus target polynucleotide, its sequence is: 5'-CCAUCCUGCUAUGCCUCGAUGG-3' (sequence 3), the 5' end is labeled with FAM fluorescence, and the 3' end is labeled with DABCYL fluorescence .

[0128] In the process of prim...

Embodiment 2

[0133] Embodiment 2 prepares the real-time fluorescent nucleic acid constant temperature amplification detection kit of hepatitis B virus (HBV)

[0134] Using the special primers and probes provided in Example 1, a real-time fluorescent nucleic acid constant temperature amplification detection kit for hepatitis B virus of the present invention was obtained. The kit contains capture probes (TCO, TargetCaptureOligo), T7 primers, nT7 primers, detection probes, internal standard detection probes, internal standards, M-MLV reverse transcriptase and T7 RNA polymerase and other components, of which:

[0135] The capture probe nucleotide sequence is SEQIDNO:4, the T7 primer sequence is SEQIDNO:1, the nT7 primer sequence is SEQIDNO:2, the detection probe nucleotide sequence is SEQIDNO:3, and the internal standard detection probe nucleotide sequence is SEQIDNO: 7.

[0136] The capture probe exists in the viral nucleic acid extraction solution, the T7 primer, nT7 primer, HBV detection p...

Embodiment 3

[0156] Example 3 Real-time fluorescent nucleic acid constant temperature amplification detection of clinical serum and plasma samples

[0157] Use kit of the present invention (capture probe, primer pair, detection probe, the composition of internal standard detection probe to see embodiment 2) detect the hepatitis B virus in clinical serum, plasma sample, compare conventional PCR detection identical Serum samples. The specific method of SAT detection includes the following steps:

[0158] 1. Sample collection, transportation and storage

[0159] The clinician will collect the specimens according to the actual situation. The serum sample collection method is as follows: use a sterile syringe to extract 2 mL of venous blood from subjects 1-16, collect it in a sterile collection tube, and centrifuge at 1600 rpm for 5 hours at room temperature for no more than 4 hours. The serum was separated within minutes and transferred to another sterile centrifuge tube for later use.

[0...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an HBV (hepatitis B virus) real-time fluorescent nucleic acid isothermal amplification detection kit, comprising a capture probe, an HBV primer, a primer T7 and a primer nT7, an HBV detection probe, an M-MLV (Moloney Murine Leukemia Virus) reverse transcriptase, polymerase T7RNA and the like reagents. A method of the invention enables high-specificity high-sensitivity low-pollution quick nucleic acid amplification detection for serum or plasma samples containing hepatitis B virus, has the advantages of high detection efficiency and high accuracy, can detect A-I 9 genotypes of HBV and has a promising application prospect.

Description

technical field [0001] The invention relates to the technical field of biomedical detection of viruses, in particular to primers and probes used in nucleic acid constant temperature amplification detection of hepatitis B virus (HBV), which combines specific target capture technology and real-time fluorescent nucleic acid constant temperature amplification detection technology and related kits. Background technique [0002] Hepatitis B virus (hepatitisBvirus, HBV) infection is a serious public health problem. About 1 million people die from liver failure, liver cirrhosis and primary hepatocellular carcinoma (liver cancer) caused by HBV infection every year in the world, and more than 75% of liver cancer patients are caused by HBV. [0003] my country is an endemic area of ​​HBV infection. According to the national hepatitis B epidemiological survey in 2006, there are about 93 million chronic HBV infected people in my country, of which about 20 million are chronic hepatitis ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/70C12Q1/6844C12R1/93
Inventor 尹华立居金良
Owner SHANGHAI RENDU BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap